Home/Filings/4/0001062993-23-010664
4//SEC Filing

Bates Jon Christian 4

Accession 0001062993-23-010664

CIK 0001479681other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:00 PM ET

Size

14.8 KB

Accession

0001062993-23-010664

Insider Transaction Report

Form 4
Period: 2023-04-01
Bates Jon Christian
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-01+49,50549,505 total
  • Exercise/Conversion

    Common Stock

    2023-04-01+20,00069,505 total
  • Award

    Restricted Stock Unit

    2023-04-01+148,515148,515 total
    Common Stock (148,515 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2023-04-0149,50599,010 total
    Common Stock (49,505 underlying)
  • Award

    Restricted Stock Unit

    2023-04-01+20,00020,000 total
    Common Stock (20,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2023-04-0120,0000 total
    Common Stock (20,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
  • [F2]Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.
  • [F3]Represents 20,000 RSUs issued and vested on April 1, 2023.

Issuer

Nutex Health, Inc.

CIK 0001479681

Entity typeother

Related Parties

1
  • filerCIK 0001938758

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:00 PM ET
Size
14.8 KB